THE BIOTRANSFORMATION OF ENDOBIOTICS BY SULFONATION
Project Number1Z01HD000194-10
Contact PI/Project LeaderSTROTT, CHARLES A.
Awardee OrganizationEUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT
Description
Abstract Text
Sulfonation is of fundamental importance in the biotransformation of
endobiotics as well as exobiotics. Sulfonation plays a primary role in
the post-translational modification of numerous structural and membrane
constituents as well as secretary proteins that is absolutely essential
for normal development and maintenance of health. The sulfonation of low
molecular weight compounds plays a crucial role in hormone action,
storage and metabolism. The universal sulfonate donor molecule, 3'-
phosphoadenosine 5'-phosphosulfate (PAPS), is synthesized by two
catalytic reactions, i.e., ATP sulfurylase and adenosine 5'-
phosphosulfate (APS) kinase. In contrast to bacteria, fungi, yeast, and
plants where the two enzymes are on separate polypeptide chains, in
higher eukaryotes, gene fusion has occurred and the two reactions are
intrinsic to a single protein (PAPS synthase). We have cloned human and
guinea pig PAPS synthase and our preliminary studies with recombinant
constructs have demonstrated that APS kinase activity resides within the
NH2-terminal domain, while ATP sulfurylase activity is located in the
COOH-terminal domain of the protein. We are currently carrying out
studies employing site-directed mutagenesis and recombinant constructs
to: 1) determine the significance of highly conserved nucleotide binding
motifs within the APS kinase domain; 2) examine a conserved FISP sequence
present in the APS kinase domain that is thought to function as a
phosphorylated intermediate in the phosphorylation of APS to form PAPS;
3) confirm that there is a common overlapping sequence which is essential
for the functionality of both ATP sulfurylase and APS kinase as suggested
by our preliminary studies; 4) determine if there is an APS binding
pocket within the overlapping sequence; 5) evaluate the regulatory
influence of the COOH-terminal segment on APS kinase activity located in
the NH2-terminal domain of PAPS synthase as suggested by our kinetic
analyses of the full-length fusion protein and the active domains
produced by recombinant techniques. The fact that PAPS is such a critical
biological molecule in mammals makes its production of vital importance.
This, in turn, clearly places PAPS synthase in a strategic position. The
more that is understood about this intriguing fused protein that
regulates the production of PAPS, the more that will be understood about
the evolution, biochemistry and biology of the sulfonation process. The
reality that sulfurylation reactions are so widespread, that they involve
an impressive legion of molecules, both large (e.g. membrane and
extracellular structural elements) and small (e.g. hormones and
neurotransmitters), coupled with the fact that PAPS is the indispensable
and universal sulfonate donor molecule in mammals, it would not be
unreasonable to suspect that knocking out the PAPS synthase gene might
prove to be lethal. In fact, the human heritable lethal disorder
achondrogenesis type 1 cogently supports this conclusion. Thus, to say
that a normally functioning PAPS synthase is mandatory for life itself
would not be an overstatement.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
DUNS Number
UEI
Project Start Date
Project End Date
Budget Start Date
Budget End Date
Project Funding Information for 1998
Total Funding
Direct Costs
Indirect Costs
Sub Projects
No Sub Projects information available for 1Z01HD000194-10
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1Z01HD000194-10
Patents
No Patents information available for 1Z01HD000194-10
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1Z01HD000194-10
Clinical Studies
No Clinical Studies information available for 1Z01HD000194-10
News and More
Related News Releases
No news release information available for 1Z01HD000194-10
History
No Historical information available for 1Z01HD000194-10
Similar Projects
No Similar Projects information available for 1Z01HD000194-10